… with various lipid-lowering nondrug and drug treatments (data not … lipid-lowering treatment
or the lipid-lowering treatments … that high doses of lipid-lowering drugs were seldom used. …

… treatment the majority do not reach the therapeutic goal. In a cross-sectional study from the
UK, only 44% of patients receiving lipid-lowering treatment reached the goal … treatment goals […

… benefits, risks, and treatment goals for lipid‐lowering therapy have not been … lipid‐lowering
medications 2 , 3 , 4 and the removal and then subsequent return of LDL‐C treatment goals in …

… to lipid-lowering and other cardioprotective therapy. Although reversing patient under-treatment
will … in-hospital initiation of currently available lipid-lowering therapies in patients with …

… third of high-risk patients having lipids measured and fewer than 10% receiving treatment.A
more aggressive stance on lipid lowering is needed, particularly for high-risk patient groups. …

… TG lowering warrants the addition of a second or third agent, known as a combination therapy.
The goal of … on the use of combination lipid-lowering therapy for ASCVD risk reduction. …

… LDL-cholesterol goal as it relates to the choice of lipid lowering therapy. Kauffman and
colleagues [19] found that, among 7427 CAD patients, 43% achieved an LDL-cholesterol goal of <…

… We also consider the prospects for treatments in development and future goals. … treatment
to a focus on LDL and to lower thresholds for initiation of therapy and lower treatment goals. …

… of lipid-lowering treatment and LDL-C treatment goals in patients at high or moderately high
risk of coronary heart disease have been set too high. This evidence has resulted in recent …

… adherence to treatment and LDL-C goal attainment according … We evaluated whether
patients attained the LDL-C goals … goal attainment within distinct windows of treatment, using …